Navigation Links
KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Date:3/25/2008

cal and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of competitive response to the Company's sales, marketing and strategic efforts; (13) risks that the Company may not ultimately prevail in litigation; (14) the completion of the Company's financial statements for the first, second and third quarters of fiscal 2008; (15) actions by the Securities and Exchange Commission and the Internal Revenue Service with respect to the Company's stock option grants and accounting practices; (16) the risks detailed from time to time in the Company's filings with the Securities and Exchange Commission; and (17) the impact of credit market disruptions on the fair value of auct
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
2. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
3. Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
7. Alseres Pharmaceuticals, Inc. Raises $5 Million
8. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
11. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 Dr. Parsa Mohebi, ... his hair transplant contest winner’s surgery on Friday, ... winner Marc R., is all set to receive his grand ... ARTAS system. His procedure will be done on a live ... To watch the surgery, go to the website and experience ...
(Date:2/26/2015)... Chicago, IL (PRWEB) February 26, 2015 ... a small step to fund powerful progress for the ... season by raising critical funds and awareness that will ... adults fighting muscle disease. , “MDA Muscle Walk events ... progress for people whose abilities to move are compromised ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has ... finalist. , The Movers & Makers Awards are ... processing, or distribution of tangible products and will be held ... event serves as Georgia’s largest local awards ceremony for manufacturing ... than 300 local industry and business leaders. , “We ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The COR ... Topical BioMedics, Inc., Rhinebeck, NY, to offer customers a ... topical biomedicine formulas that safely and effectively address muscle, ... new division of Vets Access LLC, Montrose, MI, that ... healing products. , Topical BioMedics is a research and ...
(Date:2/26/2015)... In a nested-case control study of individuals living in the ... incidence of liver cancer, statin use is associated with a ... study published February 26 in the JNCI: Journal of ... this association but most used data from individuals living in ... Asia. Katherine A. McGlynn, Ph.D., from the Division of Cancer ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3
... in the USA from recycled plastic bottles, the new Airnamic Green ... effectively removes dust, pet dander, grass and tree pollen, mold spores ... of plastic drink bottles provides consumers with an anti-microbial, moisture resistant, ... , ...
... magazine providing news and commentaries on issues that affect the ... workplace for an audience of predominantly African-American professionals, corporate executives ... Black Women in Business." , ... ...
... their newest hair loss video diaries and hair growth comparisons. The results ... video. , ... London, UK (PRWEB) February 11, 2009 -- For six ... user with video diaries. Diya Lababidi has been using one of Belgravia,s ...
... 10 Nationwide Health Properties, Inc. (NYSE: NHP ... M. Pasquale as Chairman of the Board and Robert D. ... Mr. Paulson are currently directors. These appointments will take ... Mr. Pasquale will succeed Charles D. Miller, who will remain ...
... Feb. 10 Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported significantly ... December 31, 2008. Highlights: , , , ... Third quarter net income increases 8% , ... , , For the third quarter of fiscal ...
... Feb. 10 Hanger Orthopedic Group, Inc. (NYSE: ... quarter ended December 31, 2008, an increase of $14.7 million, ... quarter. Pre-tax income increased $3.0 million, or 29.8%, to ... in the same quarter last year.Pro forma net income applicable ...
Cached Medicine News:Health News:Can a New Green Product Made From Recycled Plastic Soda Bottles Provide Cleaner Indoor Air and a Healthier Home? 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 3Health News:Best Hair Loss Treatment Results Ever Captured on Video? 2Health News:Best Hair Loss Treatment Results Ever Captured on Video? 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 9Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 10
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and specialty ... consumers, employers and government health plans $23.3 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:2/26/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) ... Equipment - Global Strategic Business Report" report to ... worldwide markets for Radiation Therapy Equipment in US$ Million ... Systems, and Radiation Therapy Simulator. The report provides separate ... , Japan , Europe ...
(Date:2/26/2015)... 26, 2015 The report, ... washer, Filler, Capper, Blow molder, Shrink wrapper), Technology ... Flavored, Sparkling) & Region - Trends & Forecasts ... the bottled water processing market with analyses and ... of value. It also identifies the driving and ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... Immucor, Inc. (Nasdaq: BLUD ), a global leader in providing automated ... generation automated instrument, NEO™, has been cleared for marketing in the U.S. ... blood bank instrument designed to meet the needs of high volume laboratories. ... "We believe there is ...
... April 30 A new study, presented at the American Society ... Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of ... , , ... in several other studies to improve breast cancer detection and aid in ...
Cached Medicine Technology:Immucor Announces FDA Clearance of NEO, the Company's Fourth Generation Automated Instrument 2BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy 2
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple, intuitive ...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... supply, with temperature probe, 100-120 and 220-240 V, ... mA, and 400 W. The temperature probe is ... 90 degrees C during electrophoresis. Built-in infrared capability ... instructions are provided. Dimensions are 27.5 x 34 ...
Medicine Products: